Signals Turns Two: Thank You

Two years ago, Signals began as a simple newsletter curating and organizing headlines and research in kidney health. That DNA is still here in our monthly recaps, but along the way, the scope and ambition of this platform grew to be something greater than I could have predicted. As I started asking more questions, online and offline, it became clear that what resonated most were the deep dives into niche topics, the data-rich figures, and the dialogue they sparked. Those conversations helped shape what Signals is today: a platform dedicated to advancing kidney health, read each month by more than 20,000 people across 54 countries.

Some of the most-read and most-shared pieces so far have included our feature on kidney care navigators, the directory of value-based care companies and future of the KCC model, five charts that explain the current state of kidney care, the recent deep dive on life on immunosuppression, and the kidney capital series — exploring who, what, how, and why early-stage ideas get funded in kidney health. These stories struck a chord because they combine data with human impact, and they’ve sparked discussions that continue well beyond the page.

Fast forward to now, we’ve added new ways to bring the community’s voice forward. Audio and video have become powerful tools for storytelling, helping us highlight perspectives from across the kidney space. Guest posts have brought fresh insight, from transitional care management billing to how kidney policy gets done, and we have more to come — including immunosuppression, mathematical modeling, and how physicians can help drive new innovations into practice. We’re also ramping up our interview series, Signals KOLs, to amplify voices across the field. Already, we’ve featured voices from organizations like ChenMed, Kaüna, Natera, Intermountain Health, Roivios, 3ive Labs, USC, Fresenius, Diality, and Providence, with many more to come. Our recent patient story with Michelle Yeboah is one of my personal favorites, and it’s why we do this. If you have someone you’d like to hear from — or want to share your own story — we’d love to hear from you, too.

The point is this: we are listening, we are ready, and this platform is for all of us. Whether you’re a clinician, a researcher, a policymaker, an innovator, an investor, or a patient, you are part of this conversation. Thank you for showing up, for sharing your perspective, and for helping shape Signals into what it has become— a one-of-a-kind platform dedicated to advancing kidney health together.

Thank you for being here, and buckle up for what’s next. =)

---

To help shape the next year, please take a minute to fill out our reader survey. Your feedback helps us know what’s resonating, what we can improve, and what else we should explore.